Price range: $180.00 through $250.00
Free bacteriostatic water with every order.
Chemical Formula: Sequence-defined (Example class structure)
Molecular Weight: ~4,000–4,500 g/mol (dependent on amino acid modifications)
CAS Number: Assigned upon structural registration
Structure: Engineered peptide designed to simultaneously activate GLP-1, GIP, and Glucagon receptor signaling pathways
Form: Lyophilized peptide powder
Solubility: Soluble in sterile water or buffered solution
Stability: Stable when frozen; limited stability after reconstitution
Half-Life: Extended compared to native incretin peptides (modified for prolonged receptor engagement)
Storage: Refrigerate at 36–46°F (2–8°C); protect from light and moisture
Binds to GLP-related receptors to influence insulin signaling and metabolic regulation
Supports glucose-dependent insulin activity and improved glycemic response in research models
Interacts with central and peripheral pathways that influence satiety and energy expenditure
Modulates downstream pathways involved in lipid metabolism and carbohydrate utilization
Studied for effects on improving insulin sensitivity and glucose control in experimental models
Investigated for potential reductions in adiposity and improved metabolic efficiency
Explored for influence on hunger signaling and caloric intake regulation
Evaluated for possible improvements in lipid markers and overall metabolic health indicators
Improves fasting glucose levels in metabolic models
Enhances post-prandial glucose regulation
Supports balanced insulin secretion
Improves lipid profiles
Reduces markers of systemic inflammation
Supports endothelial health
Phase 2 trials have shown promising results for obesity and type 2 diabetes applications with significant clinical improvements.
Dose-dependent gastrointestinal effects, temporary nausea or appetite suppression
Transient changes in blood glucose during dose escalation
Typically well tolerated in controlled research models, long-term human data remain limited
These effects appear to be dose-dependent and typically resolve after the peptide’s active pharmacological period.
Independent laboratory testing confirms purity and composition
Purity
Batch
Date
